ISDE News

The French Association of Esophageal Atresia is welcoming research project proposals aimed at improving the management of esophageal pathologies. Through this award the society wishes to draw the attention of researchers in pathology and raise awareness of the difficulties encountered by physicians who manage esophageal atresia and encourage new avenues of study. Since its creation, the AFAO has awarded 19 research prizes totaling €200,000.

Due to the rare nature of esophageal pathologies, research projects that aim to improve awareness and the treatment of these pathologies are few and far between. Since 2007, the French Association for esophageal atresia (AFAO – Association Francaise de l'Atresie de L'Esophage) has regularly asked for applications for the Prix Fanny-Selena (prior to 2017, the Prix Fanny) in memory of two girls who passed away because of their disease.

The prize has enabled research to be initiated with a clear focus on the esophagus - an essential, functional but under-researched organ.

Deadline for applications is May 15, 2022.

For more information visit https://afao.asso.fr/candidature-prix-fanny-selena-2022-application/

ISDE is committed to promoting the exchange of scientific and medical knowledge of the esophagus among specialists in the field including physicians, surgeons, basic scientists, other health professionals and members of related industries.

The society seeks to encourage basic and clinical research in fields related to the esophagus and to this end will accepts surveys for distribution with our members that fit with the vision/mission of the society. The majority of surveys accepted are research based and have passed a formal vetting process. Only survey’s that seek to investigate or expand on scientific or medical knowledge of the esophagus will be shared. A fee of $500 will apply prior to distribution and includes a follow-up reminder message to members.

Find out more in the Members Area online or contact info@isde.net to request a copy of the Policy outlining the criteria and process for submitting a request. 

Diseases of the Esophagus (DOTE)

The Official Journal of the International Society for Diseases of the Esophagus

The ISDE seeks applications for the next Co-Editor-in-Chief of the Diseases of the Esophagus Journal.

Published continuously since 1986, DOTE is a leading journal in the field of esophageal diseases with a broad international readership. The journal covers all aspects of the esophagus – epidemiology, investigation and diagnosis, and multidisciplinary treatment. The journal includes clinical research papers, short reports, commissioned review articles, correspondence, book and equipment reviews, annotated abstracts and announcements of meetings.

The 2020 Journal Impact Factor™ for Diseases of the Esophagus is 3.429; the journal is ranked 59 out of 92 in the Gastroenterology and Hepatology category.

ISDE is seeking a surgeon with an international reputation and record of academic excellence in clinical research and wide and inclusive knowledge of the field of esophagology to guide DOTE’s development and advancement over the next 4-8 years. The successful application will demonstrate:

• a strategic vision for the journal’s ongoing development;
• a commitment to diversity, inclusion, access and equity;
• the ability to work collaboratively with the editorial team, staff and publishers;
• a clear understanding of trends in scientific journal publishing, including optimizing digital functionality and the deployment of social media channels;
• an international network of colleagues; and
• prior editorial experience.

Candidates should also have a deep understanding of the challenges faced by the field of esophageal diseases with a passion to build awareness and improve its visibility, expertise in current scientific methodology.

The Co-Editors-in-Chief are supported by the Managing Editor. Additional support and resources are provided by the publishing team at Oxford University Press (OUP) and ISDE Secretariat.

Open Co-Editor Position Description

Applications should include:

• CV
• A letter (maximum 3 pages) summarizing your vision and goals for DOTE over the next 4 years, with attention to how you would like to innovate and build on DOTE’s success and to how you will promote diversity, inclusion, access and equity within the journal and the broader esophageal community. See full job description for additional guidance on points to address in your letter;

Applications should be addressed to Mark Ferguson, Executive Director and sent to info@isde.net. All applications will be reviewed by the DOTE Co-Editor-in-Chief Search Committee.

Applications are due no later than January 15, 2022. Interviews will be conducted virtually in February 2022.

It's almost the end of the year which means it's time to renew your ISDE membership. New memberships or renewals submitted from now until the end of the year are carried over to January 1, 2022. If you aren't an ISDE member, don't miss out.

• Join a community of like-minded professional peers
• Get access to regular literature updates
• Enjoy an electronic subscription to the Diseases of the Esophagus journal
• Be the first to know about new webinars
• Discounted rates to the ISDE World Congress
• Opportunities to serve on ISDE committees

Renew today and set a goal to take your professional development to the next level.

Registries and audits in esophagogastric cancer surgery play an important role in monitoring the quality of care provided to patients. During this webinar an international panel of speakers discussed the importance of registries and shared updates from around the world including set-up, results and the effect registries have had on national or regional outcomes. Panelists also discussed the way research has been incorporated into registries.

Setup and outcomes were shared from NREV (Sweden); NOGCA (England/Wales); EURECCA (Spain); (Canada/USA); (Japan), DUCA (The Netherlands).

Introduction and Defining Quality of Care in Esophagogastric Cancer Surgery

Registries and Audits: Learning from Current Nationwide Experiences

Patient Reported Outcomes in Auditing. What can we learn from them?

What is the Future of Research Within Registries

The ISDE wishes to sincerely thank the following individuals for their contributions to this presentation:

• Manuel Pera, Head of the Section of Gastrointestinal Surgery, Hospital del Mar, Spain
• Mark I. van Berge Henegouwen, Professor, University of Amsterdam, The Netherlands
• Natalie Coburn, Surgical Oncologist, Sunnybrook's Odette Cancer Center, Canada
• William Allum, Consultant Upper GI Surgeon, Royal Marsden NHS Foundation Trust, UK
• Jan Johansson, Head of Oesophageal and Gastric Surgery, Lund University Hospital, Sweden
• Sheraz Markar, Senior Oesophago-Gastric Fellow, Oxford University Hospital Trust, UK
• Pernilla Lagergren, Professor of Surgical Care Sciences, Karolinska Institutet, Sweden
• Nicholas Maynard, Consultant Upper GI Surgeon, Oxford University Hospitals NHS Trust, UK
• Masayuki Watanabe, Deputy Hospital Director, Cancer Institute Hospital of JFCR, Japan

Learn More

Checkout other presentations on our Channel ISDE Diseases of the Esophagus - YouTube

Learn more and network with others around the world at the 2022 ISDE World Congress from September 26-28, 2022 in Tokyo, Japan.

Join our Community

Become a member www.isde.net/membership

Subscribe to updates www.isde.net/Join-ISDE-Mailing-List

It is with great pleasure to present a Distinguished Membership of the International Society for Diseases of the Esophagus (ISDE) to:

• André Duranceau
• Glyn Jamieson

The criteria for this award is “being a distinguished person who has achieved prominence in the field of the esophagus and related diseases, and who has contributed to its advancement”.

Both professors have contributed in an extraordinary way to the ISDE, and the field of esophageal disease. Here are some of their notable achievements.

André Duranceau

• Represented Canada and North America on ISDE executive committees, and served as President of the Society from 2004 to 2006.
• Convened the Society’s highly successful 7th World Congress in Montreal in 1998.
• Led the transition of the Society to its current multidisciplinary membership.
• Served as Editor of Diseases of the Esophagus from 2008 to 2014, enhancing the quality and status of the journal.
• Professor Duranceau has trained many esophageal surgeons from all over the world and is a mentor to countless esophageal and thoracic surgeons. His willingness to share his expertise has impacted esophageal disease management well beyond Montreal and Canada.
  
  

Glyn Jamieson

• Advocated for ISDE in Australia and New Zealand and represented them on committees in the 1990’s and 2000’s.
• Significantly led the bid for, and then convened the ISDE’s successful World Congress in Adelaide, Australia in 2006.
• Contributed strongly to the field of esophagology with countless scholarly contributions. He edited, cowrote and published what at the time was the definitive textbook on esophageal disease in 1988 – “Surgery of the Oesophagus”. He has published more than 350 peer reviewed scientific papers across his career.

We thank both André Duranceau and Glyn Jamieson for their time, accomplishments and for advancing our field and leaving a legacy for future generations.

David Watson

ISDE Past President

We are pleased to announce the newly elected Officers and Executive Committee of the 2021 - 2022 ISDE Board of Directors.

Sheila K. Krishnadath is now the President and has activated participated in ISDE over the years. 

Also, congratulations to the following members who have been elected:

• Vice President (2021-2022): Nicholas J. Shaheen
• Director (2021-2023): Long-Qi Chen
• Director (2021-2023): Magnus Nilsson
• Director (2021-2023): Varocha Mahachai
• Director (2021-2023): Takuji Gotoda

We are confident they will have a great deal to offer in directing the future of ISDE.

Check out the latest DOTE issue for articles on Benign Esophageal and Malignant Esophageal Diseases.

Myotomy in sigmoid megaesophagus: is it applicable? A systematic review and meta-analysis
Editor's Choice - Free Article
Achalasia is a rare esophageal primary motor dysfunction with no cure. The aim of the achalasia therapy is to palliate the symptoms, mainly dysphagia. Its treatment usually focuses on inferior esophageal sphincter disruption, leading to facilitated food transit to the stomach. It can be done by surgical myotomy or endoscopic procedures, such as cardia dilatation or peroral endoscopic myotomy (POEM). Read the full article.

Severity of GERD and disease progression
Editor's Choice - Free Article
Many factors may play a role in the severity and progression of gastroesophageal reflux disease (GERD) since pathophysiology is multifactorial. Data regarding the progression of GERD are controversial: some reports of increased esophageal acid exposure (EAE) and mucosal damage were considered as evidence for a stable disease course, while others interprete these findings as disease progression. The aim of this study is to analyze a large patient-population with persisting symptoms indicative of GERD under protonpumpinhibitor-therapy and identify components characterizing disease severity and progression. Read the full article.

See the full table of contents here.

As the term has ended for some of our ISDE Board of Directors, we'd like to thank them for their service and contributions to the society. Thank you to Prateek Sharma (Past President), and Directors Manuel Pera and Edoardo Savarino. Their contributions have been invaluable in the continued development of ISDE, and in switching the Congress to a virtual platform in response to the Covid-19 pandemic. We thank you for your time and commitment and wish you all the best.

The International Society for Disease of the Esophagus (ISDE) is pleased to announce the 2022 World Congress for Esophageal Diseases will be held in Tokyo, Japan from September 26-28, 2022.

In order to serve the esophageal community better the ISDE is working closely with the Japan Esophageal Society (JES), who will be hosting their annual meeting just before the ISDE World Congress at the same venue. The programs for both society meetings will be independent and delegates may choose to attend one meeting or both.

ISDE President, Prateek Sharma was quoted as saying “Japan is known for their cutting-edge treatments in the field of endoscopy and surgical procedures. This is a great opportunity for members and attendees from around the world and from Japan to observe, learn and share information on the esophagus.”

ISDE Executive Director, Mark Ferguson commented that “the 2022 Congress in Tokyo, Japan marks the 4th time this meeting has been held in this country and honors a longstanding relationship between ISDE and the Japanese Esophageal Society (JES). We anticipate this meeting will have the highest attendance numbers of any of our congresses to date.”

We look forward to welcoming you in Tokyo!